Patent · US Active

Pegylated artesunate derivative, pharmaceutical composition and use thereof

US9623111B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Assignees

Inventors

Sicheng Li · Hangzhou City, CN
Qingbin Meng · Lo Wu, CN
Junwen Mao · Beijing, CN
Jinfeng Li · Hubei, CN
An Xu · Beijing, CN
Jia Liu · Beijing, CN
Yuanjun Liang · Beijing, CN
Qiyan Jia · Beijing, CN
Jiufeng Yan · Beijing, CN
Xiaoyang Shen · Beijing, CN
Hui Liu · Lanzhou, CN
Na Xing · 流花街道, CN

Key dates

Filing date	Apr 12, 2013
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Apr 12, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pegylated artesunate derivative, a pharmaceutical composition and uses thereof, the pegylated artesunate derivative is represented by the general formula (I):The pegylated artesunate derivative has activity comparable to that of artesunate, increased water solubility and stability, and an extended half-life in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.